Modulation by acrolein and chloroacetaldehyde of multidrug resistance mediated by the multidrug resistance-associated protein (MRP)

Clinical Cancer Research

Volumn 2, Issue 8, 1996, Pages 1321-1326

  Manzano, Ramon Gonzalez ^a   Wright, Karen A ^a   Twentyman, Peter R ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; CHLOROACETALDEHYDE; DAUNORUBICIN; VINBLASTINE;

ADENOCARCINOMA; ARTICLE; BONE MARROW TRANSPLANTATION; CELL TRANSFORMATION; CYTOTOXIC T LYMPHOCYTE; DRUG ACCUMULATION; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; METABOLIC ACTIVATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ACETALDEHYDE; ACROLEIN; ATP-BINDING CASSETTE TRANSPORTERS; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; GLUTATHIONE; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0029737045     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Calabresi, P., and Chabner, B. A. Chemotherapy of neoplastic diseases. In: A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor (eds.), The Pharmacological Basis of Therapeutics, 8th ed., pp 1202-1263. New York: Pergamon Press, 1990.
2. Santos, G. W., Tutschka, P. J., and Brookmeyer, R. Marrow transplantation for acute non-lymphocytic leukemia after treatment with busulfan and cyclophosphamide. N. Engl. J. Med., 309: 1347-1353, 1983.
3. Kennedy, M. J., Beveridge, R. A., Rowley, S. D., Gordon, G. B., Abeloff, M. D., and Davidson, N. E. High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J. Natl. Cancer Inst., 83: 920-926, 1991.
4. Sladek, N. E. Metabolism of oxazaphosphorines. Pharmacol. Ther., 37: 301-355, 1988.
5. Sood, C., and O'Brien, P. J. Molecular mechanisms of chloroacetaldehyde-induced cytotoxicity in isolated rat hepatocytes. Biochem. Pharmacol., 46: 1621-1626, 1993.
6. Crook, T. R., Souhami, R. L., Whyman, G. D., and McLean, A. E. M. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Res., 46: 5035-5038, 1986.
7. Lind, M. J., McGown, A. T., Hadfield, J. A., Thatcher, N., Crowther, D., and Fox, B. W. The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochem. Pharmacol.. 38: 1835-1840, 1989.
8. Meier, T., Allenbacher, A., Mueller, E., Multhoff, G, Botzler, C, Wiesnet, M., and Tssels, R. Tfosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesna. Anti-Cancer Drugs, 5: 403-409, 1994.
9. Cole, S. P. C . Bhardawaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. Overexpression of a novel transporter gene in a multidrug resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
10. Versantvoort, C. H. M., Broxterman, H. J., Bagrij, T., Scheper, R. J., and Twentyman, P. R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br. J. Cancer, 72: 82-89, 1995.
11. Zaman. G. J. R., Lankelma, J., Tellingen, O. V., Beijnen, J., Dekker, H., Paulusma, C., Elferink, R. P. J. O., Baas, F., and Borst, P. Role of glutathione in the export of compounds from cells by the multidrug resistance-associated protein. Proc. Natl. Acad. Sci. USA, 92: 7690-7694, 1995.
12. Twentyman. P. R., Fox, N. E., Wright, K. A., and Bleehen, N. Derivation and preliminary characterisation of Adriamycin resistant lines of human lung cancer cells. Br J Cancer, 53: 529-537, 1986.
13. Barrand, M. A., Rhodes, T., Center, M. S., and Twentyman, P. R. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur. J. Cancer, 29A: 408-415, 1993.
14. Barrand, M. A., Heppel-Parton, A. C., Wright, K. A., Rabbits, P. H., and Twentyman, P. R. A 190k protein overexpressed in non-P-glycoprotein containing MDR cells and its relation to the MRP gene. J. Natl. Cancer Inst., 86: 110-117, 1994.
15. Sedlak, J., and Lindsay, R. H Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem., 25: 192-205, 1968.
16. Watanabe, M., Sugimoto, M., and Ito, K. The acrolein cytotoxicity and cytoprotective action of alpha-tocopherol in primary cultured rat hepatocytes. Gastroenterol. Jpn , 27: 199-205, 1992.
17. Versantvoort, C. H. M., Broxterman, H. J., Pinedo, H. M., DeVries, E. G. E., Feller, N., Kuiper, C M , and Lankelma, J. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res., 52: 17-23, 1992.
18. Berhane, K., and Mameruik, B. Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu and pi. Mol. Pharmacol., 37: 251-254, 1990.
19. Dypbukt, J. M., Atzori, L., Edman, C. C., and Grafstrom, R. C. Thiol status and cytopathological effects of acrolein in normal and xeroderma pigmentosum skin fibroblasts. Carcinogenesis (Lond.), 14: 975-980, 1993.
20. Shaw, I. C., and Graham, M. I. Mesna - a short review. Cancer Treat. Rev., 14: 67-86, 1987.
21. Lee, F. Y. F. Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites. Br. J. Cancer. 63: 45-50, 1991.
22. Goren, M. P., Wright, R. K, Pratt, C. B., and Pell, F. E. Dechloroethylation of ifosfamide and neurotoxicity. Lancet, 2: 1219-1220, 1986.
23. Gurtoo, H. L., Hipkens, J. H., and Sharma, S. D. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res., 41: 3584-3591, 1981.
24. Nooter, K., Westerman, A. M., Flens, M. J., Zaman, G. J. R., Scheper, R. J., van Wingerden, K. E , Burger, H., Oostrum, R., Boerma, T., Sonneveld, P., Gratama, J. W., Kok, T., Eggermont, A. M. M., Bosman, F. T., and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res., 1: 1301-1310, 1995.